Redefining the Future of Investing: A Partnership for Growth and Innovation
About Us
Our Vision: Empowering Individuals and Communities
To be the trusted partner in building a brighter financial future, empowering individuals and communities to achieve their dreams and unlock sustainable wealth.
Our Mission: Investing in a Better Tomorrow
We are dedicated to advancing the wealth of our stakeholders by delivering innovative investment solutions, fostering meaningful growth while contributing to the development of the communities we serve. Through integrity, innovation and collaboration, we aim to create lasting value for all.
Our Impact: Empowering Communities, Driving Growth
At Black Group, we are more than just an investment firm. We are committed to making a positive difference in the communities we serve. By connecting investors with high-potential opportunities, we contribute to the growth and development of Southeast Asia. Our focus on sectors like healthcare and commercial real estate enables us to address critical societal needs while generating strong returns for our stakeholders. Through our innovative investment solutions and strategic partnerships, we strive to create a sustainable future for all.
.jpg)
Our Partners
Our Team
Tan Zi Jing
Chief Executive Officer
Black Group Investment Holding
As the Chief Executive Officer (CEO) of Black Group Investment Holding, Zi Jing leads with a dynamic spirit, driving the company’s mission and fostering a culture of innovation and fast growth. With a keen interest in the property and biotechnology sectors since 2020, Zi Jing has demonstrated a remarkable ability to identify and capitalize on emerging opportunities.
His commitment to making a difference extends to his role as Vice President of The Rotary Club Sentosa Singapore, where he serves to support projects that enhance the lives of school-going children in Cambodia. Zi Jing embodies the next generation of leaders, seamlessly blending entrepreneurial ambition with a commitment to social impact.
Dato’ Sri Alan Lee
Chief Investment Officer
Black Group Investment Holding
Alan Lee is a highly accomplished investor, Fund Manager, and Chief Investment Officer (CIO) with over 25 years of experience across a range of industries, including retail spa & wellness, beauty product manufacturing and distribution, international pageant events, and construction. He specializes in evaluating financial health, identifying investment opportunities, and managing risks to maximize returns across diverse asset classes.
With extensive expertise in financial markets—including equities, fixed income, commodities, and currencies—Alan Lee applies fundamental analysis to assess companies, construct diversified portfolios, and implement effective risk management strategies. He is skilled in financial statement analysis, market trend forecasting, and asset allocation, all aimed at enhancing returns while minimizing risk and volatility.
As an investor, Alan is adept at managing market, credit, liquidity, and operational risks, tailoring risk mitigation strategies to meet specific investment objectives. His experience also includes optimizing and rebalancing portfolios to ensure long-term growth, stability, and alignment with dynamic market conditions.
Awards & Recognition
Royal Conferment Dato Sri Paduka (2016)
Conferred by HRH Sri Paduka Kangjeng Gusti Pangeran Adipati Aria Pakualam IX Al Haj Anglingkusumo Puro Pakualam Yogyakarta, Indonesia.
Singapore Golden Brands Award (2016)
Asia Pacific Brand’s Award – Singapore’s Finest (2015)
Singapore 25 Prestige Brand Award (2014)
Prof. Lim Kah Meng
Chief Scientist
Black Group Investment Holding
Dr. Lim Kah Meng has over 20 years of experience in the life sciences research field, including two years as a research scientist at the Singapore government-funded A*STAR research institute and a postdoctoral attachment at the University of Minnesota, USA. He earned his Ph.D. in Biomedicine from the National University of Singapore in 2002, where his research focused on cell growth regulation in cancer, infectious diseases, and the development of biomedicine products. Dr. Lim’s areas of expertise include stem cell research and the study of cancerous diseases.
